Clinical Research Directory
Browse clinical research sites, groups, and studies.
Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINOCA
Sponsor: Insel Gruppe AG, University Hospital Bern
Summary
Myocardial infarction with non-obstructive coronary arteries (MINOCA) (i.e.\<50% stenoses) on coronary angiography) is an underappreciated clinical entity concerning 5-6% of patients with acute myocardial infarction. Approximately 50% of these patients remain without appropriate diagnosis and treatment. The MINOCA study aims at systematically assessing the frequency of underlying pathologies of MINOCA and outcomes with a multidisciplinary etiologic work-up and follow-up of 5 years including, for the first time, an implantable cardiac monitor (ICM) to assess the frequency of atrial fibrillation as underlying cause for MINOCA.
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2022-05-24
Completion Date
2031-05-15
Last Updated
2024-10-30
Healthy Volunteers
No
Conditions
Interventions
CONFIRM Rx implantable cardiac rhythm monitor (Abbott)
Implantation of CONFIRM Rx ICM
Systematic etiologic work-up for underlying causes of MINOCA
Intracoronary optical coherence tomography, cardiac magnetic resonance imaging, transesophageal echocardiography, vasospasm testing, thrombophilia screening, Holter ECG (only non-ICM group)
Locations (2)
Bern University Hospital Inselspital
Bern, Switzerland
University Hospital Zurich USZ
Zurich, Switzerland